We show here the defective stress response manifests a chemotherapy resistant phenotype and a growth advantage to myeloid leukaemia revealing, for the first time, TRIB2 as a tumour suppressor in myeloid leukaemia. The gene discussed is TRIB2; the disease is neoplasm.